Autopsy report · NCT02065128

The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome

“Logistical challenges with research pharmacy prevented the dilution of the capsaicin. No participants were ever recruited, enrolled, or approached.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Unity Health Toronto

Sponsor type

University, hospital or other

Conditions

Cough; Larynx

Interventions

Capsaicin cough challenge test

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• Domperidone in Refractory Gastroparesis
  “Enrolled subjects were unable to receive drug from dispensing pharmacy.” (57% match in meaning)
• Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
  “While the clinical need for and the scientific merit remain valid, this regulated drug trial was not feasible logistically due to limited funds.” (57% match in meaning)
• Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Endodontics
  “Manufacturer discontinued drug before any participants could be enrolled.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.